Skip to product information
1 of 1

BAYER SpA

Aspirin 400mg 10 effervescent tablets with vitamin C

Aspirin 400mg 10 effervescent tablets with vitamin C

Regular price €7,65
Regular price €7,65 Sale price €7,65
Sale Sold out
Tax included. Shipping calculated at checkout.
Logo Farmaci da banco
 More payment options

Pickup available at Farmacia Tili

Usually ready in 24 hours

004763114

004763114

View full details
Aspirin 400mg 10 effervescent tablets with vitamin C is a drug formulated for the symptomatic treatment of feverish states, flu and cold syndromes. Each tablet contains acetylsalicylic acid (400 mg) and ascorbic acid (240 mg), known for their analgesic and antipyretic properties. This combination is particularly effective in the treatment of headaches, dental pain, neuralgia, menstrual pain, rheumatic and muscular pain. Effervescent tablets are designed for rapid absorption, ensuring timely relief from symptoms. The addition of vitamin C not only supports the immune system, but also helps reduce the duration of flu symptoms. This product is ideal for those looking for an effective and fast remedy against the symptoms of colds and flu.

ACTIVE INGREDIENTS

Active ingredients contained in Aspirin 400mg 10 effervescent tablets with vitamin C - What is the active ingredient of Aspirin 400mg 10 effervescent tablets with vitamin C?

ASPIRIN 400 mg effervescent tablets with vitamin C One tablet contains: active ingredients : acetylsalicylic acid 400 mg ascorbic acid (Vitamin C) 240 mg For the full list of excipients, see section 6.1

EXCIPIENTS

Composition of Aspirin 400mg 10 effervescent tablets with vitamin C - What does Aspirin 400mg 10 effervescent tablets with vitamin C contain?

excipients : monosodium citrate sodium bicarbonate sodium carbonate citric acid

DIRECTIONS

Therapeutic indications Aspirin 400mg 10 effervescent tablets with vitamin C - Why is Aspirin 400mg 10 effervescent tablets with vitamin C used? What is it used for?

Symptomatic treatment of feverish states and flu and cold syndromes. Symptomatic treatment of headache and toothache, neuralgia, menstrual pain, rheumatic and muscular pain.

CONTRAINDICATIONS SIDE EFFECTS

Contraindications Aspirin 400mg 10 effervescent tablets with vitamin C - When should Aspirin 400mg 10 effervescent tablets with vitamin C not be used?

ASPIRIN effervescent tablets with vitamin C is contraindicated in case of: - hypersensitivity to the active substances (acetylsalicylic acid and ascorbic acid), to other analgesics (painkillers) / antipyretics (feverkillers) / nonsteroidal anti-inflammatory drugs (NSAIDs) or to any of the excipients; - gastroduodenal ulcer; - haemorrhagic diathesis; - severe renal, cardiac or hepatic insufficiency; - glucose-6-phosphate dehydrogenase (G6PD/favism); - concomitant treatment with methotrexate (at doses of 15 mg/week or more) or with warfarin (see section 4.5); - history of asthma induced by the administration of salicylates or substances with similar activity, in particular nonsteroidal anti-inflammatory drugs; - last trimester of pregnancy and breastfeeding (see section 4.6); - children and adolescents under 16 years of age. - Nephrolithiasis or previous history of nephrolithiasis - Hyperoxaluria - Hemochromatosis

DOSAGE

Quantity and method of taking Aspirin 400mg 10 effervescent tablets with vitamin C - How to take Aspirin 400mg 10 effervescent tablets with vitamin C?

Adults 1-2 tablets as a single dose, repeating, if necessary, the dose at intervals of 4-8 hours up to 3-4 times a day. Aspirin C must always be dissolved before use (1 tablet in half a glass of water). The product is reserved for adult patients only. Always use the lowest effective dosage and increase it only if it is not sufficient to relieve the symptoms (pain and fever). Those most at risk of serious side effects, who can use the medicine only if prescribed by a doctor, must carefully follow the instructions (see section 4.4). Use the medicine for the shortest possible period. Do not take the product for more than 3 - 5 days without consulting a doctor. Consult your doctor if symptoms persist. Take the medicine preferably after main meals or, in any case, on a full stomach. Special populations Paediatric population Aspirin effervescent tablets with vitamin C are not indicated for use in the paediatric population (see section 4.4). Elderly In elderly patients use the lowest effective dosage. Patients with impaired hepatic function Acetylsalicylic acid should be used with caution in patients with impaired hepatic function (see section 4.4). Patients with impaired renal function Acetylsalicylic acid should be used with caution in patients with impaired renal function (see section 4.4).

CONSERVATION

Storage Aspirin 400mg 10 effervescent tablets with vitamin C - How to store Aspirin 400mg 10 effervescent tablets with vitamin C?

Store below 25°C.

WARNINGS

Warnings Aspirin 400mg 10 effervescent tablets with vitamin C - About Aspirin 400mg 10 effervescent tablets with vitamin C it is important to know that:

Hypersensitivity reactions Acetylsalicylic acid and other NSAIDs may cause hypersensitivity reactions (including asthma attacks, rhinitis, angioedema or urticaria). The risk is higher in subjects who have already shown a hypersensitivity reaction after using this type of drug in the past (see section 4.3) and in subjects who have allergic reactions to other substances (e.g. skin reactions, itching, urticaria). In subjects with asthma and/or rhinitis (with or without nasal polyposis) and/or urticaria, reactions may be more frequent and severe. In rare cases, reactions may be very serious and potentially fatal. In the following cases, administration of the drug requires a doctor's prescription after careful evaluation of the risk/benefit ratio: - Subjects at increased risk of hypersensitivity reactions (see above) - Subjects at increased risk of gastrointestinal lesions Acetylsalicylic acid and other NSAIDs may cause serious gastrointestinal side effects (bleeding, ulcer, perforation). For this reason, these drugs should not be used by subjects suffering from gastrointestinal ulcers or gastrointestinal bleeding. It is also prudent that those who have suffered from gastrointestinal ulcers or gastrointestinal bleeding in the past should avoid their use. The risk of gastrointestinal lesions is a dose-related effect, as gastrolesivity is greater in subjects who use higher doses of acetylsalicylic acid. Subjects who are used to drinking large quantities of alcohol are also more exposed to the risk of gastrointestinal lesions (bleeding in particular) (see section 4.5). - Subjects with coagulation defects or undergoing treatment with anticoagulants In subjects suffering from coagulation defects or undergoing treatment with anticoagulants, acetylsalicylic acid and other NSAIDs can cause a serious reduction in haemostatic capacity, exposing them to the risk of haemorrhage. - Subjects with impaired renal or cardiac or hepatic function Acetylsalicylic acid and other NSAIDs may cause a critical reduction in renal function and fluid retention; the risk is greater in subjects treated with diuretics. This can be particularly dangerous for the elderly and for subjects with impaired renal or cardiac or hepatic function. - Subjects with asthma Acetylsalicylic acid and other NSAIDs may cause an aggravation of asthma. - Geriatric age (especially over 75 years) The risk of serious adverse effects is greater in geriatric subjects. Subjects over 70 years of age, especially in the presence of concomitant therapies, should use Aspirin only after consulting a doctor. Aspirin should not be used in the paediatric population (see section 4.3). Products containing acetylsalicylic acid should not be used in children and adolescents under 16 years of age with viral infections, regardless of whether or not fever is present. In certain viral infections, especially influenza A, influenza B and chickenpox, there is a risk of Reye's Syndrome, a very rare but life-threatening disease that requires immediate medical attention. The risk may be increased if acetylsalicylic acid is taken at the same time, although a causal relationship has not been demonstrated. Persistent vomiting in patients with these diseases may be a sign of Reye's Syndrome. - Subjects with hyperuricemia/gout Acetylsalicylic acid may interfere with the elimination of uric acid: high doses have a uricosuric effect while (very) low doses may reduce its excretion. It should also be considered that acetylsalicylic acid and other NSAIDs may mask the symptoms of gout, delaying its diagnosis. An antagonistic effect with uricosuric drugs is also possible (see section 4.5). - Subjects with a predisposition to calcium-oxal nephrolithiasis (kidney stones) or with recurrent nephrolithiasis Aspirin effervescent tablets with vitamin C : vitamin C (ascorbic acid) should be used with caution by subjects with a predisposition to calcium-oxal nephrolithiasis (kidney stones) or with recurrent nephrolithiasis. - Combinations of drugs that are not recommended or that require special precautions or dosage adjustment . The use of acetylsalicylic acid in combination with certain drugs may increase the risk of serious side effects (see section 4.5). Do not use acetylsalicylic acid together with another NSAID or, in any case, do not use more than one NSAID at a time. If you are undergoing surgery (even a minor one, such as tooth extraction) and have used acetylsalicylic acid or another NSAID in the previous days, you must inform the surgeon because of the possible effects on coagulation. Since acetylsalicylic acid can cause gastrointestinal bleeding, this must be taken into account if it is necessary to perform a test for occult blood. Before administering any medicine, all precautions to prevent adverse reactions must be taken; it is particularly important to exclude previous hypersensitivity reactions to this or other medicines and to exclude other contraindications or conditions that may expose you to the risk of potentially serious adverse effects listed above. If in doubt, consult your doctor or pharmacist. Imperfect and prolonged storage of Aspirin C may cause variations in the colour of the tablet which in itself does not affect either the activity or the tolerability of the active ingredient. In this case, it is advisable to ask the pharmacy to replace the pack. The product must be taken on a full stomach. Information on excipients This medicinal product contains 467 mg sodium per effervescent tablet equivalent to 23% of the WHO recommended maximum daily intake of 2 g sodium for an adult.

INTERACTIONS

Interactions Aspirin 400mg 10 effervescent tablets with vitamin C - Which medicines or foods can modify the effect of Aspirin 400mg 10 effervescent tablets with vitamin C?

Contraindicated combinations (avoid concomitant use - see section 4.3): - Methotrexate (doses greater than or equal to 15 mg/week) : increased plasma levels and toxicity of methotrexate; the risk of toxic effects is greater if renal function is impaired. - Warfarin: serious increase in the risk of haemorrhage due to the potentiation of the anticoagulant effect. Combinations not recommended (the concomitant use of the two drugs requires a doctor's prescription after careful evaluation of the risk/benefit ratio - see section 4.4): Antiplatelet agents: increased risk of haemorrhage due to the sum of the antiaggregant effect. Thrombolytics or oral or parenteral anticoagulants : increased risk of haemorrhage due to the potentiation of the pharmacological effect. NSAIDs (excluding topical use): increased risk of serious adverse effects. Methotrexate (doses less than 15 mg/week) : the increased risk of toxic effects (see above) must also be considered for treatment with low-dose methotrexate. Selective serotonin reuptake inhibitors (SSRIs): increased risk of upper gastrointestinal bleeding due to a possible synergistic effect. Combinations requiring special precautions or dosage adjustment (the concomitant use of the two drugs requires a doctor's prescription after careful evaluation of the risk/benefit ratio - see section 4.4): ACE inhibitors: reduction of the hypotensive effect; increased risk of renal function impairment. Valproic acid: increased effect of valproic acid (risk of toxicity). Antacids: antacids taken simultaneously with other drugs may reduce their absorption; the excretion of acetylsalicylic acid increases in alkaline urine. Antidiabetics (e.g. insulin and oral hypoglycaemics) : increased hypoglycaemic effect; the use of acetylsalicylic acid in subjects treated with antidiabetics must take into account the risk of inducing hypoglycaemia. Digoxin: increased plasma concentration of digoxin due to decreased renal elimination. Diuretics : increased risk of nephrotoxicity of acetylsalicylic acid and other NSAIDs; reduced effect of diuretics. Acetazolamide : reduced elimination of acetazolamide (risk of toxicity). Phenytoin: increased effect of phenytoin. Corticosteroids (excluding those for topical use and those used for the treatment of adrenal insufficiency): a) increased risk of gastrointestinal lesions; b) due to the increased elimination of salicylates induced by corticosteroids, plasma salicylate levels are reduced. Conversely, after stopping corticosteroid treatment, salicylate overdose may occur. Metoclopramide : increased effect of acetylsalicylic acid by increasing the rate of absorption. Uricosurics (e.g. probenecid, benzbromarone) : decreased uricosuric effect. Zafirlukast : increased plasma concentration of zafirlukast. Deferoxamine Aspirin effervescent tablets with vitamin C: concomitant use of ascorbic acid may cause increased tissue toxicity of iron, especially at cardiac level, and cause cardiac failure. Aspirin effervescent tablets with Vitamin C contain buffer systems that may reduce the effects of the thyroid hormone Levothyroxine. Alcohol (see section 4.4) The sum of the effects of alcohol and acetylsalicylic acid causes increased damage to the gastrointestinal mucosa and prolongation of bleeding time. However, it is advisable not to administer other oral medications within 1 or 2 hours of using the product. Interference with clinical laboratory tests Vitamin C Since vitamin C is a reducing agent (i.e. an electron donor), it can cause chemical interference in laboratory tests that involve oxidation-reduction reactions, such as glucose, creatinine, carbamazepine, uric acid in urine, serum and occult blood in stool. Vitamin C can interfere with tests that measure urine and blood glucose leading to a false reading of the results even if it has no effect on blood glucose levels.

SIDE EFFECTS

Like all medicines, Aspirin 400mg 10 effervescent tablets with vitamin C can cause side effects - What are the side effects of Aspirin 400mg 10 effervescent tablets with vitamin C?

The most frequently observed side effects are those affecting the gastrointestinal system and may occur in approximately 4% of subjects taking acetylsalicylic acid as an analgesic-antipyretic. This percentage increases significantly in subjects at risk of gastrointestinal disorders. These disorders can be partially alleviated by taking the medicine on a full stomach. Most of the side effects are dependent on both the dose and the duration of treatment. The side effects observed with acetylsalicylic acid are generally common to other NSAIDs. Blood and lymphatic system disorders Prolongation of bleeding time, anaemia due to gastrointestinal haemorrhage, reduction in platelets (thrombocytopenia) in extremely rare cases. Haemorrhagic/iron deficiency anaemia (due, for example, to occult microhaemorrhages) may occur following haemorrhage, with related alterations in laboratory parameters and related clinical signs and symptoms such as asthenia, pallor and hypoperfusion. Nervous system disorders Headache, dizziness. Rarely: Reye's syndrome (*) Rarely to very rarely: cerebral haemorrhage, especially in patients with uncontrolled hypertension and/or on anticoagulant therapy, which, in isolated cases, may be life-threatening. Ear and labyrinth disorders Tinnitus (ringing/buzzing/ringing/whistling in the ears). Respiratory, thoracic and mediastinal disorders Respiratory disease exacerbated by acetylsalicylic acid, asthma syndrome, rhinitis (profuse rhinorrhoea), nasal congestion (associated with hypersensitivity reactions). Epistaxis. Cardiac disorders Cardiorespiratory distress (associated with hypersensitivity reactions) Eye disorders Conjunctivitis (associated with hypersensitivity reactions) Gastrointestinal disorders Gastrointestinal bleeding (occult), gastric discomfort, heartburn, gastrointestinal pain, gingival bleeding. Vomiting, diarrhoea, nausea, crampy abdominal pain (associated with hypersensitivity reactions). Rarely: gastrointestinal inflammation, gastrointestinal erosion, gastrointestinal ulceration, haematemesis (vomiting blood or “coffee-ground” material), melaena (passage of black, tarry stools), oesophagitis. Very rarely: haemorrhagic gastrointestinal ulcer and/or gastrointestinal perforation with associated clinical signs and symptoms and alterations in laboratory parameters. Frequency not known (especially in long-term treatment): - Disease of the intestinal diaphragms. Hepatobiliary disorders Rarely: hepatotoxicity (usually mild and asymptomatic hepatocellular injury) manifested by an increase in transaminases. Skin and subcutaneous tissue disorders Rash, oedema, urticaria, pruritus, erythema, angioedema (associated with hypersensitivity reactions). Renal and urinary disorders: Impaired renal function (in the presence of altered renal haemodynamic conditions) and acute renal injury, urogenital haemorrhages. Systemic disorders and conditions related to the site of administration: Procedural haemorrhages, haematomas. Immune system disorders : Rarely: anaphylactic shock with related alterations in laboratory parameters and clinical manifestations. (*) Reye's syndrome (RS) RS initially manifests itself with vomiting (persistent or recurrent) and with other signs of encephalic suffering of varying degrees: from listlessness, drowsiness or personality changes (irritability or aggressiveness) to disorientation, confusion or delirium up to convulsions or loss of consciousness. The variability of the clinical picture must be taken into account: vomiting may also be absent or replaced by diarrhoea. If these symptoms occur in the days immediately following an episode of influenza (or flu-like or chickenpox or another viral infection) during which acetylsalicylic acid or other medicinal products containing salicylates were administered, the doctor's attention must immediately be drawn to the possibility of an RS. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important, as it allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system of the Italian Medicines Agency. Website: https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

OVERDOSE

Aspirin 400mg 10 effervescent tablets with vitamin C Overdose - What are the risks of Aspirin 400mg 10 effervescent tablets with vitamin C in case of overdose?

Acetylsalicylic Acid Salicylate toxicity (a dose greater than 100 mg/kg/day for 2 consecutive days may induce toxicity) may result from chronic ingestion of excessive doses, or from acute, potentially life-threatening overdose, including accidental ingestion in children. Chronic salicylate intoxication Chronic salicylate poisoning can be insidious since the signs and symptoms are nonspecific. Mild chronic salicylate intoxication, or salicylism, usually occurs only after repeated use of large doses. Symptoms include dizziness, vertigo, tinnitus, deafness, sweating, nausea and vomiting, headache, and confusion. These symptoms can be controlled by reducing the dosage. Tinnitus may occur at plasma concentrations between 150 and 300 micrograms/ml, while at concentrations above 300 micrograms/ml more serious adverse events occur. Acute salicylate poisoning The main feature of acute poisoning is a severe disturbance of acid-base balance, which may vary with age and severity of poisoning; the most common presentation in children is metabolic acidosis. The severity of poisoning cannot be estimated from plasma concentrations alone; absorption of acetylsalicylic acid may be delayed due to impaired gastric emptying, formation of gastric concretions, or ingestion of enteric-coated preparations. Management of acetylsalicylic acid poisoning is determined by the extent, stage, and clinical symptoms of the poisoning and should be implemented according to conventional poisoning management techniques. The main measures to be taken are to accelerate the excretion of the drug and to restore electrolytic and acid-base metabolism. Due to the complex physiopathological effects associated with salicylate poisoning, the signs and symptoms/results of biochemical and instrumental investigations may include:
Signs and symptoms Results of biochemical and instrumental investigations Therapeutic measures
MILD TO MODERATE POISONING Gastric lavage, repeated administration of activated charcoal, forced alkaline diuresis
Tachypnea, hyperventilation, respiratory alkalosis Alkalemia, alkaluria Fluid and electrolyte management
Sweating
Nausea, vomiting, headache, dizziness
MODERATE TO SEVERE POISONING Gastric lavage, repeated administration of activated charcoal, forced alkaline diuresis, haemodialysis in severe cases
Respiratory alkalosis with compensatory metabolic acidosis, Acidemia, aciduria Fluid and electrolyte management
Hyperpyrexia Fluid and electrolyte management
Respiratory: Variable from hyperventilation and non-cardiogenic pulmonary edema to respiratory arrest and asphyxia
Cardiovascular: ranging from arrhythmias and hypotension to cardiac arrest E.g. blood pressure changes, ECG changes
Loss of fluids and electrolytes: dehydration, from oliguria to renal failure E.g. hypokalemia, hyperna–tremia, hyponatremia, impaired renal function Fluid and electrolyte management
Alterations in carbohydrate metabolism, keto–si Hyperglycemia, hypoglycemia (especially in children) Increased ketone levels
Tinnitus, deafness
Gastrointestinal: gastrointestinal bleeding, gastric ulcer
Hematological: coagulopathy, iron deficiency anemia E.g. prolongation of PT, hypoprothrombinemia
Neurological: Toxic encephalopathy and CNS depression with manifestations ranging from lethargy and confusion to coma and convulsions. Cerebral edema.
Hepatic: liver damage Increased liver enzyme levels
At high doses, the following may also occur: Taste disturbances. Skin rashes (acneiform, erythematous, scarlatiniform, eczematoid, desquamative, bullous, purpuric), pruritus. Others: conjunctivitis, anorexia, reduced visual acuity, drowsiness. Rarely: aplastic anemia, agranulocytosis, disseminated intravascular coagulation, pancytopenia, leukopenia, thrombocytopenia, eosinopenia, purpura, eosinophilia associated with drug-induced hepatotoxicity, nephrotoxicity (allergic tubulointerstitial nephritis), haematuria (presence of blood in the urine). Acute allergic reactions following intake of acetylsalicylic acid can be treated, if necessary, with the administration of adrenaline, corticosteroids and an antihistamine. In case of overdose, contact a poison control center or the nearest hospital immediately. Acetylsalicylic acid is dialyzable. Ascorbic Acid Aspirin 400 mg effervescent tablets with vitamin C contains ascorbic acid: Single cases of acute and chronic overdose of ascorbic acid have been reported in the literature. Overdose of ascorbic acid may cause oxidative haemolysis in patients with glucose-6-phosphate dehydrogenase deficiency, disseminated intravascular coagulation and significantly elevated serum and urinary oxalate levels. Increased oxalate levels have been shown to result in the formation of calcium oxalate deposits in dialysis patients. High doses of vitamin C may cause calcium oxalate deposits, calcium oxalate crystalluria in patients with a predisposition to crystal formation, tubulointerstitial nephropathy and acute renal failure secondary to calcium oxalate crystals.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Aspirin 400mg 10 effervescent tablets with vitamin C.

Fertility The use of acetylsalicylic acid, as with any drug inhibiting the synthesis of prostaglandins and cyclooxygenase, may interfere with fertility; female subjects, particularly women who have fertility problems or who are undergoing investigations of fertility, must be informed of this. Pregnancy Inhibition of prostaglandin synthesis may adversely affect pregnancy and/or embryo/foetal development. Results of epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk of cardiac malformations was increased from less than 1%, up to approximately 1.5%. It has been estimated that the risk increases with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to cause an increase in pre- and post-implantation loss and embryo-foetal mortality. In addition, an increased incidence of various malformations, including cardiovascular, has been reported in animals given prostaglandin synthesis inhibitors during the organogenetic period. During the first and second trimester of pregnancy, acetylsalicylic acid should not be given unless clearly necessary. If drugs containing acetylsalicylic acid are used by a woman attempting to conceive, or during the first and second trimester of pregnancy, treatment should be as short as possible and the dose as low as possible. During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose: the fetus to: - cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension); - renal dysfunction, which may progress to renal failure with oligo-hydroamniosis; the mother and the unborn child, at the end of pregnancy, to: - possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses; - inhibition of uterine contractions resulting in delayed or prolonged labor. Consequently, acetylsalicylic acid is contraindicated during the third trimester of pregnancy. Breastfeeding ASPIRIN 400 mg effervescent tablets with vitamin C is contraindicated during breastfeeding (see section 4.3).

DRIVING AND USE OF MACHINERY

Taking Aspirin 400mg 10 effervescent tablets with vitamin C before driving or using machines - Does Aspirin 400mg 10 effervescent tablets with vitamin C affect driving or using machines?

Due to the possible occurrence of headache or dizziness, this medicine may impair the ability to drive vehicles and use machines.
  • HELP CENTER

  • SHIPPING

    Shipping in Italy 24/48H
    Delivery also on Saturday and Sunday
    Free over €49.90


    Shipping in Europe 24/72H
    Free over €80

  • SAFETY

    The security of your data matters to us!


    We are fully compliant with the European GDPR regarding Privacy and Processing of personal data.


    Payments you make on our site are 100% safe and guaranteed.

  • RETURNS

    Fast returns through do-it-yourself portal and 14 days to reconsider.


    Fast and free replacements for incorrect or non-compliant products delivered.

NaN of -Infinity

Responsibility for content
This sheet contains information that is not intended to replace a diagnosis or medical advice, as only a doctor can write any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note
The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they could be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the published information.

Data source: Farmadati Italia
Website: www.farmadati.it

The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalists, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory.

The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.